Repotrectinib(Augtyro)

Another NameAugtyro、洛普替尼、奥凯乐、Repotrectinib、瑞普替尼

IndicationsAdult patients with locally advanced or metastatic ROS1 positive non-small cell lung cancer (NSCLC).